Search results for "Endolymphatic Hydrops"

showing 5 items of 5 documents

Intratympanic gentamicin treatment after endolymphatic sac surgery.

2005

Interval treatment with up to three intratympanic gentamicin injections once weekly effectively controlled vertigo while preserving hearing in patients with Ménière's disease and recurrent or resistant vertigo after saccotomy.Recurrent or resistant incapacitating vertigo may occur after endolymphatic sac surgery (saccotomy) in patients with Ménière's disease. In these patients, revision saccotomy, vestibular nerve section or labyrinthectomy are the established treatment options. We advocate a once-weekly application of intratympanic gentamicin (12 mg) as an effective alternative in this group of patients.Five patients (age range 39-65 years) with definite Ménière's disease according to the …

AdultMalemedicine.medical_specialtyEar MiddleEndolymphatic sacInjectionsPostoperative ComplicationsRecurrenceVertigootorhinolaryngologic diseasesmedicineHumansEndolymphatic HydropsEndolymphatic hydropsMeniere DiseaseAntibacterial agentAgedbiologymedicine.diagnostic_testbusiness.industryAminoglycosideElectronystagmographyAuditory ThresholdGeneral MedicineMiddle Agedbiology.organism_classificationmedicine.diseaseSurgerymedicine.anatomical_structureOtorhinolaryngologyElectronystagmographyVertigoAudiometry Pure-ToneGentamicinFemaleEndolymphatic SacGentamicinsbusinessmedicine.drugMeniere's diseaseFollow-Up StudiesActa oto-laryngologica
researchProduct

Meniere's disease: Therapeutic options

2021

Meniere's disease (MD) is characterized by the triad of fluctuating hearing loss, episodic vertigo and tinnitus, and by endolymphatic hydrops found on postmortem examinations. Since the description of endolymphatic hydrops by Hallpike and Cairns, the physiopathology of Meniere's symptoms has been based on assumption that the pathologic lesion was the cause of the symptoms. Schuknecht proposed the theory of membranous rupture causing the mixing up of endolymph and perilymph leading to the occurrence of Meniere's symptoms. Lawrence confirmed this theory with research on experimental animals. In 1995 the AAO-HNS criteria defines "Possible MD (Grade D), Probable MD (Grade C), Definite MD (Grade…

Endolymphatic hydropsMeniere diseaseInner earHearing lossDeafness
researchProduct

Evolution of migraine vertigo in overlapping syndrome with ménière’s disease: Prognostic role of instrumental examination

2021

Migraine vertigo (MV) and Ménière's disease (MD) share several signs and symptoms such as tinnitus, fullness, photophobia, phonophobia, headache and vertigo spells lasting hours.The aim of the present study was to prospectively observe patients with MV with a sporadic audiological symptom evaluated with clinical examination, Vestibular Evoked Myogenic Potentials (VEMPs), ECochG and v-HIT.The finding of VEMP asymmetry, according to our cut-off of 33% of difference between sides, resulted in 20 cases, of which 6 had asymmetry of both c-VEMPs and o-VEMPS, all with development of fluctuating hearing during follow-up. ECochG was positive for endolymphatic hydrops in 12 patients.The evolution of …

medicine.medical_specialtyMénière’s diseasePhotophobiaVestibular evoked myogenic potentialMigraine DisordersAudiologyvertigineVestibology03 medical and health sciences0302 clinical medicineOverlapping syndromeVertigootorhinolaryngologic diseasesmedicineVestibular migraineHumansEndolymphatic HydropsEndolymphatic hydropssindrome da sovrapposizione030223 otorhinolaryngologyelettrococleografiaMeniere Diseaseemicrania vestibolarebiologyECochGbusiness.industrybiology.organism_classificationmedicine.diseasePrognosismalattia di MénièreGeneral EnergyPhonophobiaVEMPsOtorhinolaryngologyMigraine030220 oncology & carcinogenesisVertigomedicine.symptombusinessTinnitusMeniere's disease
researchProduct

Comparison of Electrocochleography and Video Head Impulse Test findings in Vestibular Migraine and Ménière Disease: A Preliminary Study

2020

OBJECTIVES: To evaluate electrophysiological findings among patients with vestibular migraine (VM) and to compare them with those of patients suffering from definite Ménière disease (MD) without migraine. MATERIALS and METHODS: Twenty-one consecutive patients suffering from VM were enrolled; all subjects were selected according to the criteria proposed by the Bàràny Society for Neuro-otology. Each patient underwent a careful otological and neurotological examination. After completing a questionnaire regarding migraine and vertigo complaints, they were assessed by audiometric testing, video head impulse test (vHIT), and elec-trocochleography (EcochG). Data were compared with those of 21 pati…

AdultMalemedicine.medical_specialtyMigraine DisordersEcochGMénière diseaseVestibular migraineMENIERE DISEASEDiagnosis Differential03 medical and health sciences0302 clinical medicineInternal medicineVertigomedicineVestibular migraineHumansEndolymphatic hydrops030223 otorhinolaryngologyHead Impulse TestMeniere Diseasebiologybusiness.industrySignificant differenceReproducibility of ResultsHead impulse testGeneral MedicineElectrocochleographyMiddle Agedmedicine.diseasebiology.organism_classificationlcsh:Otorhinolaryngologylcsh:RF1-547Audiometry Evoked ResponseEndolymphatic hydropsOtorhinolaryngologyMigraineVestibular DiseasesEndolymphatic hydropEcochG Endolymphatic hydrops Ménière disease Vestibular migraineFemaleOriginal Articlebusiness030217 neurology & neurosurgeryJournal of International Advanced Otology
researchProduct

Intratympanic gentamicin: a one day protocol treatment for unilateral Meniere’s disease.

2007

Purpose: The objective of this study was to assess the usefulness of low-dose intratympanic gentamicin administration in patients with Meniere’s disease (MD). Materials and Methods: We carried out a retrospective review of the charts of 55 patients with definite MD in accordance with the AAO-HNS (American Academy of Otolaryngology–Head and Neck Surgery) Diagnostic Scale who were treated at Gruppo Otologico (Piacenza, Rome, Italy). The treatment protocol consisted of 3 intratympanic injections of gentamicin at a 12-hour interval between each administration. Results: Results were resumed in accordance with AAO-HNS criteria and showed complete control of vertigo spells in 60% (class A), good c…

vertigoIntratympanic gentamicinEndolymphatic hydropsgentamicinMeniere’s disease
researchProduct